MLR-1023 – 50 mg

Brand:
Cayman
CAS:
41964-07-2
Storage:
-20
UN-No:
Non-Hazardous - /

MLR-1023 is an allosteric activator of Lyn kinase (EC50 = 63 nM).{34026} It has no significant activity against a panel of related kinases. MLR-1023 is orally bioavailable and reduces blood glucose levels in mice subjected to an oral glucose tolerance test.{34026} This effect is insulin-dependent, with MLR-1023 increasing insulin receptor sensitivity.{34025} MLR-1023 produces a dose-dependent and durable glucose-lowering effect in chronically treated db/db mice without causing weight gain.{34025}  

 

Out of stock

SKU: 21496 - Category:

Description

An allosteric activator of Lyn kinase (EC50 = 63 nM); reduces blood glucose levels in mice subjected to an oral glucose tolerance test; increases insulin receptor sensitivity


Formal name: 5-(3-methylphenoxy)-2(1H)-pyrimidinone

Synonyms:  CP 26,154|NSC 314335

Molecular weight: 202.2

CAS: 41964-07-2

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Activators|Kinases||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes